Wondering whether Vertex Pharmaceuticals is still worth buying at around $452 a share, or if the big gains are already behind ...

These companies could innovate their way to success.

Vertex Pharmaceuticals recently reported clinical data showing that CASGEVY helped all evaluable children aged 5–11 with ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

The following players span a variety of industries, so if you pick up more than one, you may gain in diversification.

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

One of the practical applications of thinking long-term is to buy and hold exceptional stocks with strong growth prospects.

The International Society for Stem Cell Research (ISSCR) today opened its sold-out international symposium, Accelerating ...

According to TipRanks.com, Risinger is a 5-star analyst with an average return of 21.2% and a 61.3% success rate. Risinger covers the Healthcare sector, focusing on stocks such as Centessa ...

CFOs, including Gunnar Wiedenfels of Warner Bros Discovery and Colette Kress of Nvidia, addressed disciplined spending, ...

Nandkumar M. Kamat As the year is about to end, here is a short review of important breakthroughs in science that defined the ...